SG Americas Securities’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,273
| Closed | -$253K | – | 2927 |
|
|
2025
Q1 | $253K | Sell |
21,273
-8,813
| -29% | -$105K | ﹤0.01% | 2106 |
|
|
2024
Q4 | $567K | Buy |
30,086
+7,141
| +31% | +$135K | ﹤0.01% | 1047 |
|
|
2024
Q3 | $516K | Sell |
22,945
-80,254
| -78% | -$1.8M | ﹤0.01% | 1468 |
|
|
2024
Q2 | $2.15M | Buy |
103,199
+81,005
| +365% | +$1.69M | 0.01% | 845 |
|
|
2024
Q1 | $326K | Sell |
22,194
-4,407
| -17% | -$64.7K | ﹤0.01% | 1465 |
|
|
2023
Q4 | $275K | Buy |
26,601
+5,962
| +29% | +$61.6K | ﹤0.01% | 1707 |
|
|
2023
Q3 | $162K | Buy |
+20,639
| New | +$162K | ﹤0.01% | 2221 |
|
|
2023
Q2 | – | Sell |
-23,725
| Closed | -$211K | – | 2532 |
|
|
2023
Q1 | $211K | Buy |
23,725
+350
| +1% | +$3.11K | ﹤0.01% | 2168 |
|
|
2022
Q4 | $257K | Sell |
23,375
-498
| -2% | -$5.48K | ﹤0.01% | 1833 |
|
|
2022
Q3 | $311K | Sell |
23,873
-10,348
| -30% | -$135K | ﹤0.01% | 1746 |
|
|
2022
Q2 | $434K | Buy |
+34,221
| New | +$434K | ﹤0.01% | 1886 |
|
|
2022
Q1 | – | Sell |
-14,599
| Closed | -$423K | – | 2852 |
|
|
2021
Q4 | $423K | Sell |
14,599
-10,493
| -42% | -$304K | ﹤0.01% | 2041 |
|
|
2021
Q3 | $752K | Buy |
25,092
+16,094
| +179% | +$482K | ﹤0.01% | 1978 |
|
|
2021
Q2 | $239K | Buy |
8,998
+1,504
| +20% | +$39.9K | ﹤0.01% | 2042 |
|
|
2021
Q1 | $233K | Buy |
+7,494
| New | +$233K | ﹤0.01% | 2340 |
|